Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for WAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 201.00M
March 31, 2026 -3.00M
December 31, 2025 141.23M
September 30, 2025 187.31M
June 30, 2025 41.14M
March 31, 2025 259.55M
December 31, 2024 240.14M
September 30, 2024 204.58M
June 30, 2024 54.53M
March 31, 2024 262.87M
December 31, 2023 230.12M
September 30, 2023 157.82M
June 30, 2023 18.12M
March 31, 2023 196.75M
December 31, 2022 198.71M
September 30, 2022 158.09M
June 30, 2022 56.90M
March 31, 2022 197.96M
December 31, 2021 217.94M
September 30, 2021 167.89M
June 30, 2021 143.04M
March 31, 2021 218.40M
December 31, 2020 267.48M
September 30, 2020 172.58M
June 30, 2020 198.81M
Date Value
March 31, 2020 151.64M
December 31, 2019 191.90M
September 30, 2019 148.39M
June 30, 2019 127.02M
March 31, 2019 175.78M
December 31, 2018 181.55M
September 30, 2018 146.34M
June 30, 2018 100.72M
March 31, 2018 175.84M
December 31, 2017 192.18M
September 30, 2017 154.20M
June 30, 2017 177.05M
March 31, 2017 174.21M
December 31, 2016 172.97M
September 30, 2016 139.20M
June 30, 2016 157.02M
March 31, 2016 159.89M
December 31, 2015 153.65M
September 30, 2015 139.09M
June 30, 2015 112.96M
March 31, 2015 154.59M
December 31, 2014 161.72M
September 30, 2014 127.84M
June 30, 2014 106.33M
March 31, 2014 115.76M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 519.00M
Thermo Fisher Scientific, Inc. 2.125B
Danaher Corp. 1.534B
Revvity, Inc. 191.94M
Illumina, Inc. 201.00M